These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1089265)
21. Clinical experience with fluocinonide in 90 out-patients. Eichenberger H Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):87. PubMed ID: 5291640 [No Abstract] [Full Text] [Related]
22. [Synalar gel in the treatment of dermatoses]. Kalamkarian AA; Samsonov VA; Grebeniuk VN Sov Med; 1975 Apr; (4):152-3. PubMed ID: 1188451 [No Abstract] [Full Text] [Related]
23. [The noxious effects of steroids in local application]. Sneddon IB Bull Soc Fr Dermatol Syphiligr; 1970; 77(5):670-2. PubMed ID: 5518188 [No Abstract] [Full Text] [Related]
24. [Synalar in the treatment of patients with various dermatoses]. Sakhnovskaia AI; Minasov VS; Taĭts KT Vestn Dermatol Venerol; 1966 Apr; 40(4):78-9. PubMed ID: 5988462 [No Abstract] [Full Text] [Related]
25. Comparative studies with 0.025 per cent fluocinolone acetonide cream and 0.2 per cent fluocinolone acetonide cream. Flatt RS J Fla Med Assoc; 1968 Dec; 55(12):1091-2. PubMed ID: 5725869 [No Abstract] [Full Text] [Related]
26. [Experience in the use of Synalar in the treatment of patients with various dermatoses]. Grebenkina EA; Kotina RI; Tikhonova AIa; Buryleva KG; Fridman EL Vestn Dermatol Venerol; 1966 Apr; 40(4):79-80. PubMed ID: 5988463 [No Abstract] [Full Text] [Related]
27. [Synalar in the treatment of psoriasis and several other chronic dermatoses]. Ashmarin IuIa; Amitan BIa Vestn Dermatol Venerol; 1966 Apr; 40(4):81-3. PubMed ID: 5988466 [No Abstract] [Full Text] [Related]
28. [Experience in the use of Synalar for the external treatment of patients with various dermatoses]. Arievich AM; Studnitsin AA; Panova LM Vestn Dermatol Venerol; 1966 Apr; 40(4):75-8. PubMed ID: 5988461 [No Abstract] [Full Text] [Related]
29. [Methods of clinical trial of a local corticoid]. Craps L; Ferner U Arch Belg Dermatol Syphiligr; 1972; 28(2):97-110. PubMed ID: 4570340 [No Abstract] [Full Text] [Related]
30. [Clinical experimentation with a new topical corticosteroid: fluocinonide]. Coppolino C; Sposato N Arch Ital Dermatol Venereol Sessuol; 1971; 37(1):5-12. PubMed ID: 4260100 [No Abstract] [Full Text] [Related]
31. [Topical treatment of alopecia areata--a double blind test using 0.025 per cent and 1.2 per cent fluocinolone acetonide cream]. Azumi T; Sasada K; Yasue A; Watanabe T Hifuka Kiyo; 1971 Feb; 66(1):63-79. PubMed ID: 4948970 [No Abstract] [Full Text] [Related]
32. Percutaneous absorption of corticosteroids: systemic effects. Scoggins RB; Kliman B N Engl J Med; 1965 Oct; 273(16):831-40. PubMed ID: 5825903 [No Abstract] [Full Text] [Related]
33. [Clinical experiences with fluocinonide FAPG]. Reiffenstuhl B; Wolf D Wien Med Wochenschr; 1973 Sep; 123(38):555-6. PubMed ID: 4270843 [No Abstract] [Full Text] [Related]
34. [Clinical results of 0.06 and 0.03 percent Rinderon V ointment and cream]. Okuwa H; Niwa Y; Fujimoto N Acta Dermatol Kyoto Engl Ed; 1967 Feb; 62(1):62-4. PubMed ID: 5630466 [No Abstract] [Full Text] [Related]
35. [The use of "Synalar" ointment in the treatment of patients with various dermatoses]. Prorvich LV; Zudin BI Vestn Dermatol Venerol; 1966 Apr; 40(4):73-5. PubMed ID: 6011191 [No Abstract] [Full Text] [Related]
36. Necrosis in leg ulcers. Probable role of fluocinolone acetonide. Bjornberg A; Hellgren L Arch Dermatol; 1965 Jul; 92(1):52-3. PubMed ID: 11850953 [TBL] [Abstract][Full Text] [Related]
37. [Clocortolone (Cl 68) versus fluocinolone, a double-blind, randomized lateral comparison]. Borelli S; Gartmann H; Klaschka F Hautarzt; 1973 Jul; 24(7):294-7. PubMed ID: 4269321 [No Abstract] [Full Text] [Related]
38. Photosensitivity following treatment with occlusive dressings. Cattano AN Arch Dermatol; 1970 Sep; 102(3):276-9. PubMed ID: 5456017 [No Abstract] [Full Text] [Related]
39. [Occlusive therapy of dermatosis with fluocinolone acetonide]. Armentano E Clin Ter; 1967 Jul; 42(2):141-6. PubMed ID: 5596412 [No Abstract] [Full Text] [Related]
40. [Value of 0.025 percent fluocinolone acetonide in dry dermatoses]. Laure M; Mari Mars Med; 1968; 105(3):287-8. PubMed ID: 5739898 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]